MyFinsight
Home
Blog
About
Contact
Download
Download image
Total revenues
$36,751M
(9.95%↑ Y/Y)
Other segment items
-$931M
(-455.34%↓ Y/Y)
Interest income
$408M
(-20.00%↓ Y/Y)
Net income
$7,711M
(88.53%↑ Y/Y)
Depreciation, amortization
and other
$5,167M
(-7.60%↓ Y/Y)
Canceled cashflow
$30,379M
Accrued sales
incentives and allowance
$2,065M
(72.95%↑ Y/Y)
Impairment of intangible
assets
$1,200M
Inventories
-$886M
(65.01%↑ Y/Y)
Accrued liabilities
$499M
(442.39%↑ Y/Y)
Stock-based compensation
expense
$494M
(-6.79%↓ Y/Y)
Accounts payable
$428M
(37.18%↑ Y/Y)
Long-term tax liabilities
$311M
(163.21%↑ Y/Y)
Other items, net
-$149M
(-1962.50%↓ Y/Y)
Net cash provided by
operating activities
$9,958M
(-13.33%↓ Y/Y)
Canceled cashflow
$8,952M
Manufacturing cost of sales
$9,845M
(-11.45%↓ Y/Y)
Research and development
$7,272M
(21.93%↑ Y/Y)
Sales and marketing
$4,590M
(-2.61%↓ Y/Y)
Interest expense, net
$2,755M
(-12.68%↓ Y/Y)
General and
administrative
$2,460M
(3.23%↑ Y/Y)
Profit share and
royalties in cost of sales
$2,192M
(25.98%↑ Y/Y)
Provision for income taxes
$1,265M
(143.74%↑ Y/Y)
(decrease) increase in cash
and cash...
-$2,844M
(-376.38%↓ Y/Y)
Canceled cashflow
$9,958M
Trade receivables,
net
$2,676M
(706.80%↑ Y/Y)
Accrued income taxes,
net
-$2,068M
(-104.55%↓ Y/Y)
(gains) losses on equity
securities
$2,064M
(1398.11%↑ Y/Y)
Other assets
$1,267M
(94.33%↑ Y/Y)
Deferred income taxes
-$721M
(41.29%↑ Y/Y)
Other liabilities
-$156M
(-205.88%↓ Y/Y)
Net cash (used in)
provided by financing...
-$10,859M
(-15.34%↓ Y/Y)
Net cash used in
investing activities
-$1,943M
(-85.76%↓ Y/Y)
Dividends paid
$5,124M
(6.04%↑ Y/Y)
Repayment of debt
$5,000M
(38.89%↑ Y/Y)
Extinguishment of debt
$683M
(3.64%↑ Y/Y)
Other
-$52M
(58.06%↑ Y/Y)
Purchases of property,
plant and equipment
$1,858M
(69.53%↑ Y/Y)
Cash paid for
acquisitions, net of cash...
$53M
Other
$32M
(164.00%↑ Y/Y)
Back
Back
Cash Flow
source: myfinsight.com
amgen-blue-svg
AMGEN INC (AMGN)
amgen-blue-svg
AMGEN INC (AMGN)